Simon D. Baines

3.0k total citations · 1 hit paper
37 papers, 2.3k citations indexed

About

Simon D. Baines is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Simon D. Baines has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 22 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Simon D. Baines's work include Clostridium difficile and Clostridium perfringens research (35 papers), Microscopic Colitis (21 papers) and Viral gastroenteritis research and epidemiology (17 papers). Simon D. Baines is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (35 papers), Microscopic Colitis (21 papers) and Viral gastroenteritis research and epidemiology (17 papers). Simon D. Baines collaborates with scholars based in United Kingdom, Mexico and Netherlands. Simon D. Baines's co-authors include Jane Freeman, Mark H. Wilcox, Warren N. Fawley, Ed J. Kuijper, Martijn P. Bauer, Abraham Goorhuis, Jeroen Corver, M. H. Wilcox, G. S. Crowther and S. L. Todhunter and has published in prestigious journals such as PLoS ONE, Clinical Microbiology Reviews and Journal of Bacteriology.

In The Last Decade

Simon D. Baines

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Changing Epidemiology of Clostridium difficile Infections

2010 641 citations Jane Freeman, Simon D. Baines et al. profile →

Peers

Countries citing papers authored by Simon D. Baines

Since Specialization

Citations

This map shows the geographic impact of Simon D. Baines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon D. Baines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon D. Baines more than expected).

Fields of papers citing papers by Simon D. Baines

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon D. Baines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon D. Baines. The network helps show where Simon D. Baines may publish in the future.

Co-authorship network of co-authors of Simon D. Baines

This figure shows the co-authorship network connecting the top 25 collaborators of Simon D. Baines. A scholar is included among the top collaborators of Simon D. Baines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon D. Baines. Simon D. Baines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model 2023 ·Antibiotics ·(unknown), César Rodríguez, Céline Harmanus, Ingrid M. J. G. Sanders, Igor A. Sidorov, (unknown), Emily Savage, Andrew R. Timms, Jane Freeman, Wiep Klaas Smits, Mark H. Wilcox, Simon D. Baines	5
2	Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole 2021 ·Microbial Drug Resistance ·Adrián Martínez-Meléndez, (unknown), (unknown), Simon D. Baines, Rayo Morfín‐Otero, Adrián Camacho-Ortíz, Licet Villarreal-Treviño, Elvira Garza‐González	1
3	Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico 2021 ·Enfermedades Infecciosas y Microbiología Clínica ·Adrián Martínez-Meléndez, Rayo Morfín‐Otero, Licet Villarreal-Treviño, Simon D. Baines, Adrián Camacho-Ortíz, Elvira Garza‐González	5
4	Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes 2020 ·Journal of Microbiological Methods ·Adrián Martínez-Meléndez, Rayo Morfín‐Otero, Licet Villarreal-Treviño, Simon D. Baines, Adrián Camacho-Ortíz, Elvira Garza‐González	24
5	High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates 2019 ·PLoS ONE ·(unknown), Licet Villarreal-Treviño, Simon D. Baines, Rayo Morfín‐Otero, Adrián Camacho-Ortíz, Samantha Flores-Treviño, Héctor Jesús Maldonado-Garza, Eduardo Rodríguez-Noriega, Elvira Garza‐González	20
6	Circulation of Highly Drug-Resistant Clostridium difficile Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico 2018 ·Microbial Drug Resistance ·Adrián Martínez-Meléndez, (unknown), Rayo Morfín‐Otero, Adrián Camacho-Ortíz, Licet Villarreal-Treviño, (unknown), Eduardo Rodríguez-Noriega, Simon D. Baines, Samantha Flores-Treviño, Héctor Jesús Maldonado-Garza, Elvira Garza‐González	14
7	Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome 2017 ·PLoS ONE ·Adrián Camacho-Ortíz, (unknown), José F. García-Mazcorro, Soraya Mendoza-Olazarán, Adrián Martínez-Meléndez, (unknown), Simon D. Baines, (unknown), Elvira Garza‐González	34
8	Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model 2014 ·Journal of Antimicrobial Chemotherapy ·G. S. Crowther, C. H. Chilton, S. L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, M. H. Wilcox	35
9	Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota 2014 ·PLoS ONE ·G. S. Crowther, C. H. Chilton, S. L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, Mark H. Wilcox	39
10	SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model 2014 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, G. S. Crowther, Jane Freeman, S. L. Todhunter, Richard Vickers, Mark H. Wilcox	35
11	Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery 2013 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, Jane Freeman, Simon D. Baines, G. S. Crowther, Scott Nicholson, Mark H. Wilcox	21
12	Mixed infection by Clostridium difficile in an in vitro model of the human gut 2013 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, G. S. Crowther, S. L. Todhunter, Jane Freeman, C. H. Chilton, Warren N. Fawley, Mark H. Wilcox	12
13	Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection 2012 ·Journal of Antimicrobial Chemotherapy ·G. S. Crowther, Simon D. Baines, S. L. Todhunter, Jane Freeman, C. H. Chilton, M. H. Wilcox	96
14	Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model 2011 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, (unknown), (unknown), S. L. Todhunter, (unknown), Joanne K. Hobbs, Jane Freeman, A. M. Lovering, (unknown)	31
15	Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model 2008 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, Rory J O’Connor, Katherine Saxton, Jane Freeman, Mark H. Wilcox	47
16	In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin 2008 ·Journal of Antimicrobial Chemotherapy ·Rory J O’Connor, Simon D. Baines, Jane Freeman, Mark H. Wilcox	16
17	Emergence of reduced susceptibility to metronidazole in Clostridium difficile 2008 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, (unknown), Jane Freeman, Warren N. Fawley, Céline Harmanus, Paola Mastrantonio, Ed J. Kuijper, M. H. Wilcox	207
18	Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model 2007 ·Journal of Antimicrobial Chemotherapy ·Jane Freeman, Simon D. Baines, (unknown), Mark H. Wilcox	81
19	Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model 2006 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, Katherine Saxton, Jane Freeman, Mark H. Wilcox	67
20	Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection 2005 ·Journal of Antimicrobial Chemotherapy ·Jane Freeman, Simon D. Baines, Daniela Jabés, Mark H. Wilcox	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact